Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Update

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totaling 74,962 shares, a decline of 53.6% from the July 15th total of 161,665 shares. Currently, 1.4% of the company’s shares are sold short. Based on an average daily volume of 202,909 shares, the days-to-cover ratio is currently 0.4 days.

Nanovibronix Price Performance

FEED stock traded up $0.06 during midday trading on Friday, hitting $0.44. 857,848 shares of the stock traded hands, compared to its average volume of 1,576,550. Nanovibronix has a 1-year low of $0.29 and a 1-year high of $17.40. The stock’s fifty day simple moving average is $0.52 and its 200-day simple moving average is $1.35. The firm has a market cap of $2.66 million, a P/E ratio of -0.05 and a beta of 1.38.

Nanovibronix (NASDAQ:FEED) last posted its earnings results on Monday, May 18th. The company reported ($6.88) earnings per share (EPS) for the quarter. Nanovibronix had a negative return on equity of 54.25% and a negative net margin of 923.20%.The firm had revenue of $0.65 million for the quarter.

Insider Activity

In other news, insider Christian Michael Glibert sold 210,000 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 12.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on FEED. Wall Street Zen upgraded Nanovibronix from a “strong sell” rating to a “sell” rating in a research report on Sunday, July 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nanovibronix in a report on Tuesday, July 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.